Treating depression with atypical features

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 3, 2007, Pages 25-29

  Stewart, Jonathan W ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; FLUOXETINE; GEPIRONE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PLACEBO; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTHRALGIA; ASTHENIA; ATYPICAL DEPRESSION; BACKACHE; BEHAVIOR THERAPY; CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; COUGHING; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; TREMOR; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HISTORY, 20TH CENTURY; HUMANS; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS;

EID: 33847722309     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Matza LS, Revicki DA, Davidson JR, et al. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 2003;60:817-826
2. Liebowitz MR, Quitkin FM, Stewart JW, et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988;45:128-137
3. Quitkin FM, McGrath PJ, Stewart JW, et al. Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 1990;47:935-941
4. Quitkin FM, McGrath PJ, Stewart JW, et al. Phenelzine and imipramine in mood reactive depressives. Arch Gen Psychiatry 1989;46:787-793
5. Quitkin FM, Harrison W, Stewart JW, et al. Response to phenelzine and imipramine in placebo nonresponders with atypical depression: a new application of the crossover design. Arch Gen Psychiatry 1991;48:319-323
6. McGrath PJ, Stewart JW, Nunes EV, et al. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. Am J Psychiatry 1993;150:118-123
7. McGrath PJ, Stewart JW, Harrison W, et al. A placebo-controlled trial of L-deprenyl in atypical depression. Psychopharmacol Bull 1989;25:63-67
8. Pande AC, Birkett M, Fechner-Bates S, et al. Fluoxetine versus phenelzine in atypical depression. Biol Psychiatry 1996;40:1017-1020
9. Lonnqvist J, Sihvo S, Syvalahti E, et al. Moclobemide and fluoxetine in atypical depression: a double-blind trial. J Affect Disord 1994;32:169-177
10. Sogaard J, Lane R, Latimer P, et al. A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. J Psychopharmacol 1999;13:406-414
11. Jarrett RB, Schaffer M, McIntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:431-437
12. Beck AT, Rush AJ, Shaw BF, et al. Cognitive Therapy of Depression. Guilford Clinical Psychology and Psychotherapy Series. New York, NY: Guilford; 1979
13. McGrath PJ, Stewart JW, Janal MN, et al. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. Am J Psychiatry 2000;157:344-350
14. McGrath PJ, Stewart JW, Quitkin FM, et al. Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement. J Clin Psychopharmacol 1994;14:347-352
15. Davidson JR, Abraham K, Connor KM, et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261-264
16. Docherty JP, Sack DA, Roffman M, et al. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiatr Pract 2005;11:302-314